Related Experiment Video
Updated: Apr 18, 2026

Generation of a RIP1 Knockout U937 Cell Line Using the CRISPR-Cas9 System
Published on: April 11, 2025
RIP1 modulates death receptor mediated apoptosis and autophagy in macrophages
Zhenyu Yao1, Peng Zhang2, Hui Guo2
1National Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100005, China; Institute of Biomedical and Health Engineering Shenzhen Institutes of Advanced Technology, CAS, China.
Abstract:
Macrophages are responsible for defending against diverse pathogens and play a crucial role in the innate immune system. Macrophage's lifespan is determined by homeostatic balance between survival and apoptosis. Here we report that tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) triggers both apoptosis and autophagy in human U937 cells. Inhibition of autophagy facilitates TRAIL-induced apoptosis, suggesting that autophagy of macrophages protects against TRAIL-induced apoptosis. TRAIL treatment influences the expression of death receptors, indicating that TRAIL-induced apoptosis and autophagy are mediated by death receptors. RIP1 ubiquitination and expression regulate apoptosis and autophagy. Furthermore, expression and bioactivity of the p43/41-caspase-8 variant are critical to TRAIL-induced autophagy and apoptosis. Knockdown of RIP1 suppresses autophagy in macrophage. These data demonstrate that RIP1 is essential for the regulation of death receptor mediated autophagy and apoptosis. The results in this study contribute to understanding the regulation of autophagy and apoptosis in macrophages, and shed lights on death receptor-targeted therapy for cancer, inflammation and autoimmune diseases.
Insights
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) triggers apoptosis and autophagy in macrophages. Inhibiting autophagy enhances TRAIL-induced apoptosis, revealing autophagy
Area of Science:
- Immunology
- Cell Biology
Background:
- Macrophages are key immune cells regulating pathogen defense and innate immunity.
- Macrophage lifespan depends on the balance between cell survival and programmed cell death (apoptosis).
Purpose of the Study:
- To investigate the roles of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in macrophage apoptosis and autophagy.
- To elucidate the regulatory mechanisms of TRAIL-induced apoptosis and autophagy in macrophages.
Main Methods:
- Utilized human U937 macrophage cell line.
- Investigated TRAIL-induced apoptosis and autophagy.
- Analyzed the roles of death receptors, RIP1 ubiquitination, and caspase-8 variants.
- Performed RIP1 knockdown experiments.
Main Results:
- TRAIL induces both apoptosis and autophagy in U937 cells.
- Autophagy inhibition enhances TRAIL-induced apoptosis, indicating a protective role for autophagy.
- TRAIL-induced apoptosis and autophagy are mediated by death receptors and regulated by RIP1 ubiquitination and expression.
- The p43/41-caspase-8 variant is critical for TRAIL-induced autophagy and apoptosis.
- RIP1 knockdown suppresses macrophage autophagy.
Conclusions:
- RIP1 is essential for regulating death receptor-mediated autophagy and apoptosis in macrophages.
- Understanding these pathways offers insights into targeted therapies for cancer, inflammation, and autoimmune diseases.
Related Concept Videos
The Extrinsic Apoptotic Pathway
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Regulation of the Unfolded Protein Response
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...
Cellular Injury V: Apoptosis and Autophagy
The Intrinsic Apoptotic Pathway

